Hässelby, Sweden

Kjell S Sakariassen


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Hasselby, SE (2002)
  • Hässelby, SE (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kjell S Sakariassen: Innovator in Pharmaceutical Formulations

Introduction

Kjell S Sakariassen is a notable inventor based in Hässelby, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination formulations for treating diseases related to the 5-HT receptor. With a total of 2 patents, his work has the potential to impact therapeutic practices significantly.

Latest Patents

One of his latest patents focuses on a pharmaceutical combination formulation and method of treatment involving a 5-HT receptor agonist and antagonist. This invention aims to prevent or treat diseases associated with the 5-HT receptor by administering these compounds in effective amounts to provide a therapeutic effect. The patent also includes a pharmaceutical composition that comprises an effective amount of the combination, along with a pharmaceutically acceptable carrier.

Career Highlights

Kjell S Sakariassen is associated with Biovitrum AB, a company known for its innovative approaches in biotechnology and pharmaceuticals. His work at Biovitrum has allowed him to explore and develop groundbreaking solutions in the medical field.

Collaborations

Throughout his career, Sakariassen has collaborated with esteemed colleagues such as Jan Svartengren and Patrizia Caldirola. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kjell S Sakariassen stands out as an influential inventor in the pharmaceutical industry, with his innovative approaches to treating diseases related to the 5-HT receptor. His contributions continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…